NFE2L2 and skin cancer: Similarly to Nrf2 null mice, mice engineered with an inactive, dominant-negative Nrf2 mutant transgene develop skin cancer at three times the frequency of control mice in a classical two-stage model of chemical carcinogenesis [39].